Abstract
Background
Estimating the national burden of influenza disease is challenging. We aimed to estimate the disease burden of seasonal influenza in Spain, at the primary care and hospital level, over the 6 influenza seasons after 2009 pandemic.
Methods
We used data from the Spanish Influenza Sentinel Surveillance System to estimate weekly influenza rates and the number of influenza‐like illness (ILI) and mild confirmed influenza cases (MCIC). From the surveillance of severe hospitalized confirmed influenza cases (SHCIC), we obtained hospitalization rates and total number of SHCIC, intensive care unit (ICU) admissions and deaths in influenza hospitalized patients. We estimated both mild and severe influenza cases, overall, and by age‐group (<5, 5‐14, 15‐64, and ≥65 years).
Results
The highest cumulative rates of MCIC were observed in <15 years (1395‐3155 cases/100 000 population in 5‐14 years) and the lowest in ≥65 years (141‐608 cases/100 000 population). SHCIC rates revealed a characteristic U‐shaped distribution, with annual average hospitalization rates of 16.5 and 18.9 SHCIC/100, 000 p in 0‐4 years, and ≥65 years, respectively. We estimated an annual average of 866 868 cases of ILI attended in primary care (55% were MCIC), 3616 SHCIC, 1232 ICU admissions, and 437 deaths in SHCIC. The percentage of ICU admission among SHCIC was highest at 15‐64 years (42%), while the hospitalization fatality rate ranged from 1% in 0‐4 years to 18% in ≥65 years.
Conclusions
The ongoing Spanish Influenza Surveillance System allowed obtaining crucial information regarding the impact of mild and severe influenza in Spain.
Keywords: burden disease, influenza, primary care, secondary care, Spain, surveillance
1. INTRODUCTION
Seasonal influenza is an acute respiratory infection caused by worldwide circulating influenza viruses. The spectrum of disease severity ranges from mild forms of disease to those with severe complications, including death. The main aim of influenza immunization programs is the reduction of hospitalization and death occurring mainly among high‐risk individuals. However, the burden of mild outpatient illness is also important because it accounts for a large proportion of absenteeism in both healthy adults and children.1
Current estimates indicate that, worldwide, the annual influenza epidemics affect 5%‐10% of the world's population, resulting in about 3‐5 million cases of severe illness, and about 250 000‐500 000 deaths.1 The European Center for Disease Prevention and Control (ECDC) estimates that nearly 40 000 people in the European Union die prematurely each year due to influenza‐related causes.2
To better assess and plan targeted public health interventions, national estimates of the burden of seasonal influenza are needed to compare between different influenza seasons and pandemics.
Estimating the national burden of influenza disease is however challenging. Recently, the WHO issued recommendations toward the use of influenza surveillance data to better estimate the burden of disease at the national level.3
The Spanish Influenza Sentinel Surveillance System (SISSS) is a well‐established and consolidated system that provides timely information on the activity of mild influenza disease in Spain at primary care level since 1996.4, 5 It is based on sentinel physicians reporting clinical influenza‐like illness (ILI) cases and integrates virological data collected in the same population,6 providing an opportunity to calculate the disease burden in primary care. Regarding influenza severity, the surveillance system for severe hospitalized confirmed influenza cases (SHCIC) was established in Spain after the influenza pandemic of 2009, including sentinel hospitals from all Spanish regions.
To date, estimates of influenza‐associated disease burden in Spain have been focused on specific age‐groups,7 regional geographical areas,8 or severe disease but have not considered mild influenza disease.9 Our aim was to utilize data obtained by the SISSS and SHCIC on the surveillance of mild and severe disease at the primary and secondary care level to estimate the age related burden of seasonal influenza disease in Spain, in the post‐2009 pandemic period.
2. METHODS
2.1. The Spanish Influenza Sentinel Surveillance System (SISSS)
The SISSS comprises 17 networks of sentinel physicians (general practitioners and pediatricians) in 17 of the 19 Spanish regions, as well as the network‐affiliated laboratories, including the National Influenza Reference Laboratory (National Centre for Microbiology, World Health Organization National Influenza Centre in Madrid). More than 800 sentinel physicians participated each season covering a population under surveillance of around 1 million of physician's catchment area, giving an overall coverage of 2.2% of the total population of the 17 Spanish regions. All the networks complied with a series of requirements as to the minimum population covered (>1%) and representativeness in terms of age, sex, and degree of urbanization.4, 5
Sentinel physicians reported ILI cases detected in their reference populations on a weekly basis, following a definition based on the EU‐ILI case definition.10 For influenza surveillance, they systematically swabbed (nasal or nasopharyngeal) the first 2 ILI patients each week and sent the swabs to the network‐affiliated laboratories for influenza virus detection. The information collected in the SISSS includes data on demographic, clinical and virological characteristics, seasonal vaccination status, chronic conditions, and pregnancy. Data are entered weekly by each regional sentinel network in a web‐based application (http://vgripe.isciii.es/gripe) and analyzed by the National Centre of Epidemiology to provide timely information on the evolving influenza activity in Spanish regions and at the national level.
We used data provided by the SISSS for the 2010‐2011 to 2015‐2016 influenza seasons. We calculated the cumulative weekly ILI rates by season, for all ages and by age‐group (0‐4, 5‐14, 15‐64, and >64 years). By extrapolation to the Spanish population we estimated the number of ILI cases by age and season and by applying the corresponding weekly positivity rate, we estimated the number of mild confirmed influenza cases (MCIC). Point estimates and 95% confidence intervals (95% CI) were calculated.
2.2. Surveillance of SHCIC
The number of hospitals participating in the surveillance of SHCIC ranged between 181 in the post‐pandemic season 2010‐2011 and 90 in the 2013‐2014 influenza season. The population under surveillance reached 60% of the total Spanish population in the 2010‐2011 season and was maintained around 45% from the 2011‐2012 season onwards. The catchment population in the surveillance of SHCIC was the reference population of each participating hospital in each season, who would be referred to those hospitals for any reason leading to hospitalization. As the Spanish secondary health system provides national public coverage to almost all the Spanish population, the catchment hospital population is completely generalizable nationwide.
The system is based on the notification of those laboratory confirmed influenza hospitalized cases in all wards who met the Spanish SHCIC case definition. This case definition includes several severity criteria: “Any case with clinical features compatible with influenza, requiring hospitalization for clinical severity: at least one of the following criteria: pneumonia, septic shock, acute respiratory distress syndrome, multiple organ dysfunction syndrome, or admission to ICU.” Although it was recommended to swab all influenza cases needing to be hospitalized, in the clinical practice, the extent of respiratory swabbing might depend of the hospital physician's discretion. Following swabbing, only those cases that were influenza confirmed and meet the case definition were reported. Data on clinical, epidemiological, and virological information were collected, as well as the patient outcome. In this way, one unique system provides information on all hospitalized patients with severe confirmed influenza infection, including the ICU‐admitted and deceased.
We used data obtained from the surveillance of SHCIC for the same study period and age‐groups as in primary care, to calculate the cumulative hospitalization rates as well as the cumulative rates of ICU admission for each season. We used as denominators the population under surveillance in the participating hospitals. These rates were applied to the total Spanish population to estimate the total number of SHCIC and ICU‐admitted patients (including the 95% CI) for the whole country, by season and age‐group. The number of deaths in SHCIC was also extrapolated to the Spanish population to estimate the number of deaths in influenza hospitalized patients in Spain.
We used as denominators the Spanish population of the first year of each season (total and by age‐group), obtained from the Spanish National Statistics Institute.11
All estimations were performed using version 14.1 of the statistical analysis software stata (Stata Corp., College Station, TX, USA).
3. RESULTS
3.1. Seasonality of influenza activity in Spain through the Influenza Surveillance Systems in primary and secondary care
Influenza activity in sentinel primary care varied by studied season (Figure 1). The ILI rates at the epidemic peak ranged between 348 ILI cases per 100 000 population, in the 2014‐2015 season, and 195 ILI cases per 100 000 population, in the 2015‐2016 season. There was a predominant circulation of A(H1N1)pdm09 in the 2010‐2011, 2013‐2014 (with co‐circulation of A[H3N2]), and 2015‐2016 season; influenza A(H3N2) predominated in the 2011‐2012, 2013‐2014 (co‐circulating with A[H1N1]pdm09), and 2014‐2015 season. The influenza B predominated in the 2012‐2013 season, although influenza B virus also circulated in a considerable extent following the peak of 2010‐2011, 2014‐2015, and 2015‐2016 influenza seasons. Three epidemics had a usual presentation on time reaching the peak in January (2010‐2011, 2013‐2014, 2014‐2015) and 3 peaked later, toward middle‐end of February (2011‐2012, 2012‐2013, and 2015‐2016).
Figure 1.
Primary care. Weekly ILI rates and number of type/subtype influenza virus by season, SISSS, Spain
The weekly number of SHCIC, ICU admissions and deaths in influenza hospitalized patients along the 6 studied influenza seasons is shown in Figure 2. The total number of SHCIC ranged from 525 in the 2012‐2013 season to 3101 in the 2015‐2016 season.
Figure 2.
Secondary care. Weekly number of severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients, surveillance of SHCIC, Spain
We provide here results at national level. Influenza activity observed at primary and secondary health care in Spain varied by Spanish region and season and was timely reported through the national weekly and annual influenza reports.
3.2. Estimated influenza burden disease
3.2.1. ILI cases and MCIC in sentinel primary care
The highest cumulative MCIC rates were observed in children under 15, whereas the lowest in the elderly (65+ aged) (Figure 3). The cumulative MCIC rates varied from 141 to 608 cases per 100 000 population in the elderly, depending on the season, and from 1395 to 3155 cases per 100 000 population in the 5‐ to 14‐year age‐group.
Figure 3.
Primary care. Cumulative annual rates of mild confirmed influenza cases by age group, SISSS, Spain
The number of ILI cases in Spain in the study period ranged between 792 783 in 2013‐2014 and 984 061 in 2014‐2015 influenza season; approximately 50% of them were MCIC ranging between 431 468 in 2010‐2011 and 580 331 in 2014‐2015 influenza season (Table 1).
Table 1.
Influenza‐like illness (ILI) and mild confirmed influenza cases attended in primary care by age‐group. SISSS, Spain, seasons 2010‐2011 to 2015‐2016
| Season | Dominant influenza type/subtype | ILI cases | Mild confirmed influenza cases | ||||
|---|---|---|---|---|---|---|---|
| Number | 95% CI | Number | 95% CI | ||||
| All ages | |||||||
| 2010/11 | A(H1N1)2009 | 860 490 | 858 673 | 862 310 | 431 468 | 430 182 | 432 757 |
| 2011/12 | A(H3N2) | 893 685 | 891 833 | 895 540 | 482 108 | 480 748 | 483 471 |
| 2012/13 | B | 844 907 | 843 106 | 846 711 | 464 483 | 463 148 | 465 821 |
| 2013/14 | A(H1N1)2009 | 792 783 | 791 039 | 794 530 | 438 519 | 437 222 | 439 819 |
| 2014/15 | A(H3N2) | 984 061 | 982 118 | 986 007 | 580 331 | 578 839 | 581 826 |
| 2015/16 | A(H1N1)2009 | 825 283 | 823 503 | 827 066 | 450 735 | 449 420 | 452 053 |
| Aged 65+ | |||||||
| 2010/11 | A(H1N1)2009 | 41 054 | 40 658 | 41 453 | 11 096 | 10 890 | 11 304 |
| 2011/12 | A(H3N2) | 73 548 | 73 017 | 74 081 | 44 550 | 44 137 | 44 966 |
| 2012/13 | B | 45 865 | 45 446 | 46 287 | 17 708 | 17 448 | 17 971 |
| 2013/14 | A(H1N1)2009 | 54 121 | 53 666 | 54 579 | 26 532 | 26 214 | 26 853 |
| 2014/15 | A(H3N2) | 88 673 | 88 090 | 89 259 | 51 228 | 50 785 | 51 674 |
| 2015/16 | A(H1N1)2009 | 51 940 | 51 494 | 52 389 | 22 078 | 21 788 | 22 371 |
| 15‐64 y | |||||||
| 2010/11 | A(H1N1)2009 | 532 282 | 530 853 | 533 714 | 270 056 | 269 038 | 271 076 |
| 2011/12 | A(H3N2) | 519 805 | 518 393 | 521 220 | 263 827 | 262 821 | 264 836 |
| 2012/13 | B | 473 313 | 471 966 | 474 663 | 256 924 | 255 931 | 257 919 |
| 2013/14 | A(H1N1)2009 | 520 517 | 519 104 | 521 933 | 296 631 | 295 564 | 297 700 |
| 2014/15 | A(H3N2) | 578 879 | 577 389 | 580 372 | 329 361 | 328 237 | 330 488 |
| 2015/16 | A(H1N1)2009 | 449 705 | 448 392 | 451 021 | 239 399 | 238 441 | 240 360 |
| 5‐14 y | |||||||
| 2010/11 | A(H1N1)2009 | 192 861 | 192 001 | 193 724 | 106 189 | 105 551 | 106 830 |
| 2011/12 | A(H3N2) | 171 381 | 170 571 | 172 194 | 99 214 | 98 598 | 99 833 |
| 2012/13 | B | 219 807 | 218 889 | 220 728 | 139 215 | 138 485 | 139 948 |
| 2013/14 | A(H1N1)2009 | 123 587 | 122 899 | 124 278 | 64 914 | 64 416 | 65 415 |
| 2014/15 | A(H3N2) | 219 132 | 218 215 | 220 051 | 148 999 | 148 243 | 149 758 |
| 2015/16 | A(H1N1)2009 | 198 662 | 197 789 | 199 538 | 120 573 | 119 893 | 121 256 |
| 0‐4 y | |||||||
| 2010/11 | A(H1N1)2009 | 94 292 | 93 691 | 94 896 | 44 127 | 43 716 | 44 541 |
| 2011/12 | A(H3N2) | 128 952 | 128 249 | 129 658 | 74 517 | 73 983 | 75 054 |
| 2012/13 | B | 105 922 | 105 285 | 106 562 | 50 636 | 50 196 | 51 079 |
| 2013/14 | A(H1N1)2009 | 94 558 | 93 956 | 95 163 | 50 442 | 50 003 | 50 884 |
| 2014/15 | A(H3N2) | 97 377 | 96 766 | 97 991 | 50 744 | 50 303 | 51 187 |
| 2015/16 | A(H1N1)2009 | 124 977 | 124 285 | 125 672 | 68 685 | 68 172 | 69 201 |
There were differences in the estimated burden of influenza in primary care by age. In elderly, we estimated the highest annual number of MCIC (from 44 550 to 51 228) in the A(H3N2) dominant influenza seasons 2011‐2012 and 2014‐2015, respectively (Table 1). The 5‐ to 14‐year age‐group was most affected in the B season 2012‐2013 (139 215) and also in the A(H3N2) season 2014‐2015 (148 999) and the A(H1N1)pdm09 season 2015‐2016 (120 573 (Table 1). For children less than 5 years old, the annual number of MCIC was highest in the A(H3N2) season 2011‐2012, with 74 517 MCIC.
3.2.2. SHCIC, ICU admissions and influenza deaths in secondary care
Surveillance in secondary care evidenced for all the influenza seasons the highest annual cumulative SHCIC in the extreme age‐groups: 0‐4 and 65+ years old. We estimated between 8 and 30 hospitalizations per 100 000 population for the children up to 4 years old and between 4 and 30 hospitalizations per 100 000 population in the elderly group, depending on the influenza season (Figure 4).
Figure 4.
Secondary care. Cumulative annual rates of severe hospitalized confirmed influenza cases by age group, surveillance of SHCIC, Spain
In the study period, there was an annual average of 3616 SHCIC (Table 2). On average, the estimated severe hospitalized rates were highest in children under 4 years of age (18.9 SHCIC/100 000 population) and in elderly (16.5 SHCIC/100 000 population). ICU admission rates were also highest in these age‐groups, with 4.9 ICU admissions/100 000 population and 4.5 ICU admissions/100 000 population in children <4 years and in elderly, respectively. There was an annual average of 437 influenza hospitalized deaths. Annual influenza hospitalized rates were highest in the elderly (3 deaths in influenza hospitalized patients/100 000 population) (Table 2).
Table 2.
Annual average number and cumulative rates of severe hospitalized confirmed influenza cases, ICU admissions, and deaths in influenza hospitalized patients, Spain, 2010‐2011 to 2015‐2016
| Age‐group | SHCIC | ICU admissions | Deaths in influenza hospitalized patients | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Rate per 100 000 pop | 95% CI | N | Rate per 100 000 pop | 95% CI | N | Rate per 100 000 pop | 95% CI | |
| All ages | 3616 | 7.8 | 7.5‐8.0 | 1232 | 2.6 | 2.5‐2.8 | 437 | 0.9 | 0.8‐1.0 |
| Aged 65+ | 1403 | 16.5 | 15.7‐17.4 | 383 | 4.5 | 4.1‐5.0 | 254 | 3.0 | 2.6‐3.4 |
| 15‐64 y | 1651 | 5.3 | 5.1‐5.6 | 700 | 2.3 | 2.1‐2.4 | 170 | 0.5 | 0.4‐0.6 |
| 5‐14 y | 107 | 2.3 | 1.9‐2.7 | 33 | 0.7 | 0.5‐1.0 | 3 | 0.1 | 0.0‐0.2 |
| 0‐4 y | 426 | 18.9 | 17.1‐20.8 | 110 | 4.9 | 4.0‐5.9 | 4 | 0.2 | 0.1‐0.4 |
The number of SHCIC in Spain in the study period ranged between 1221 in the 2012‐2013 and 6694 in the 2015‐2016 season; the number of ICU admissions ranged between 464 in 2011‐2012 and 2312 in 2015‐2016 season; the number of deaths in influenza hospitalized patients ranged between 115 in 2011‐2012 and 760 in 2015‐2016 season (Table 3).
Table 3.
Severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients by age‐group, surveillance of SHCIC, Spain, seasons 2010‐2011 to 2015‐2016
| Season | Dominant influenza type/subtype | SHCIC | ICU admissions | Deaths in influenza hospitalized patients | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number | 95% CI | Number | 95% CI | Number | 95% CI | |||||
| All ages | ||||||||||
| 2010/11 | A(H1N1)2009 | 2751 | 2649 | 2856 | 1017 | 955 | 1081 | 325 | 291 | 362 |
| 2011/12 | A(H3N2) | 1405 | 1332 | 1480 | 464 | 423 | 508 | 115 | 95 | 138 |
| 2012/13 | B | 1221 | 1153 | 1291 | 472 | 430 | 517 | 126 | 105 | 150 |
| 2013/14 | A(H1N1)2009 | 5483 | 5339 | 5630 | 1874 | 1790 | 1961 | 667 | 617 | 720 |
| 2014/15 | A(H3N2) | 4139 | 4014 | 4267 | 1251 | 1183 | 1322 | 629 | 581 | 680 |
| 2015/16 | A(H1N1)2009 | 6694 | 6535 | 6856 | 2312 | 2219 | 2408 | 760 | 707 | 816 |
| Aged 65+ | ||||||||||
| 2010/11 | A(H1N1)2009 | 472 | 430 | 517 | 137 | 115 | 162 | 90 | 72 | 111 |
| 2011/12 | A(H3N2) | 546 | 501 | 594 | 189 | 163 | 218 | 73 | 57 | 92 |
| 2012/13 | B | 352 | 316 | 391 | 116 | 96 | 139 | 69 | 54 | 87 |
| 2013/14 | A(H1N1)2009 | 2052 | 1964 | 2143 | 553 | 508 | 601 | 393 | 355 | 434 |
| 2014/15 | A(H3N2) | 2366 | 2272 | 2463 | 586 | 540 | 635 | 465 | 424 | 509 |
| 2015/16 | A(H1N1)2009 | 2632 | 2532 | 2735 | 714 | 663 | 768 | 433 | 393 | 476 |
| 15‐64 y | ||||||||||
| 2010/11 | A(H1N1)2009 | 1777 | 1695 | 1862 | 762 | 709 | 818 | 226 | 197 | 257 |
| 2011/12 | A(H3N2) | 371 | 334 | 411 | 159 | 135 | 186 | 35 | 24 | 49 |
| 2012/13 | B | 567 | 521 | 616 | 277 | 245 | 312 | 47 | 35 | 63 |
| 2013/14 | A(H1N1)2009 | 2825 | 2722 | 2931 | 1169 | 1103 | 1238 | 258 | 227 | 291 |
| 2014/15 | A(H3N2) | 1205 | 1138 | 1275 | 506 | 463 | 552 | 143 | 121 | 168 |
| 2015/16 | A(H1N1)2009 | 3160 | 3051 | 3272 | 1327 | 1257 | 1400 | 313 | 279 | 350 |
| 5‐14 y | ||||||||||
| 2010/11 | A(H1N1)2009 | 102 | 83 | 124 | 26 | 17 | 38 | 2 | 0 | 7 |
| 2011/12 | A(H3N2) | 65 | 50 | 83 | 18 | 11 | 28 | 2 | 0 | 7 |
| 2012/13 | B | 85 | 68 | 105 | 24 | 15 | 36 | 2 | 0 | 7 |
| 2013/14 | A(H1N1)2009 | 111 | 91 | 134 | 35 | 24 | 49 | 7 | 3 | 14 |
| 2014/15 | A(H3N2) | 126 | 105 | 150 | 41 | 29 | 56 | 5 | 2 | 12 |
| 2015/16 | A(H1N1)2009 | 155 | 132 | 181 | 53 | 40 | 69 | 2 | 0 | 7 |
| 0‐4 y | ||||||||||
| 2010/11 | A(H1N1)2009 | 404 | 366 | 445 | 95 | 77 | 116 | 5 | 2 | 12 |
| 2011/12 | A(H3N2) | 411 | 372 | 453 | 92 | 74 | 113 | 2 | 0 | 7 |
| 2012/13 | B | 210 | 183 | 240 | 54 | 41 | 70 | 5 | 2 | 12 |
| 2013/14 | A(H1N1)2009 | 471 | 429 | 516 | 113 | 93 | 136 | 4 | 1 | 10 |
| 2014/15 | A(H3N2) | 379 | 342 | 419 | 104 | 85 | 126 | 5 | 2 | 12 |
| 2015/16 | A(H1N1)2009 | 683 | 633 | 736 | 204 | 177 | 234 | 2 | 0 | 7 |
Regarding the burden of severe influenza disease by age‐group, in influenza seasons with predominant A(H1N1)pdm09 circulation, we estimated the highest number of SHCIC in young adults: 1777, 2825, and 3160, for the 2010‐2011, 2013‐2014, and 2015‐2016 influenza seasons, respectively (Table 3). ICU admissions and deaths in influenza hospitalized patients were also highest in those seasons. In children less than 5 years old, the season 2015‐2016 yielded the highest number of SHCIC and ICU admissions, 683 and 204, respectively. In elderly, we estimated the highest number of deaths in influenza hospitalized patients in the A(H3N2) 2014‐2015 season, accounting for 465 deaths (95%IC: 424‐509) (Table 3).
Of the total estimated number of SHCIC and ICU admissions, 46% and 57%, respectively, were in the young adults group, followed by the elderly (39% and 31%). Only 23 deaths in hospitals were estimated for children less than 5 years old, while the majority of deaths occurred in the 65+ age‐group (58%), followed by the 15‐64 age‐group (39%) (Figure 5).
Figure 5.
Percentage of severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients by age group, Spain, seasons 2010–11 to 2015–16
Within the 6 influenza seasons 2010‐2011 to 2015‐2016, the percentage of ICU admission among the SHCIC was highest (42%) in the 15‐64 age‐group, while the hospitalization fatality rate was highest in elderly (18% of deaths among SHCIC) (Table 4). Children 0‐4 and 5‐14 years old experienced a percentage of ICU admission of 31% and 26%, respectively, but the hospitalization fatality rate was very low (1%‐3%) compared to the young adults and elderly (10% and 18%, respectively) (Table 4).
Table 4.
Number and percentage of ICU admissions and deaths in influenza hospitalized patients, Spain, 2010‐2011 to 2015‐2016
| Age‐group | SHCIC | ICU admissions | Deaths in influenza hospitalized patients | ||||
|---|---|---|---|---|---|---|---|
| N | N | Percentage of admission | 95% CI | N | Hospitalization fatality rates | 95% CI | |
| All ages | 21 693 | 7390 | 34.1 | 33.4‐34.7 | 2622 | 12.1 | 11.7‐12.5 |
| Aged 65+ | 8420 | 2295 | 27.3 | 26.3‐28.2 | 1523 | 18.1 | 17.3‐18.9 |
| 15‐64 y | 9905 | 4200 | 42.4 | 41.4‐43.4 | 1022 | 10.3 | 9.7‐10.9 |
| 5‐14 y | 644 | 197 | 30.6 | 27.0‐34.3 | 20 | 3.1 | 1.9‐4.7 |
| 0‐4 y | 2558 | 662 | 25.9 | 24.2‐27.6 | 23 | 0.9 | 0.5‐1.3 |
4. DISCUSSION
We estimated the burden of mild and severe seasonal influenza during the post‐2009 pandemic period in Spain, using information from influenza surveillance systems at the primary care and hospital level. The burden of seasonal influenza has been substantial in Spain, with an annual average of 866 868 ILI cases attended in sentinel primary care, of which 55% were influenza confirmed (474 607 MCIC). At the hospital level, we estimated an annual average of 3616 episodes of severe confirmed influenza hospitalizations, 1232 episodes of influenza ICU admissions, and 437 deaths in influenza hospitalized patients.
The SISSS and the surveillance of SHCIC are the only nationally systems for ILI patients attended in sentinel primary care and for severe influenza hospitalized patients, representative for the Spanish population, incorporating both epidemiological and virological surveillance. These systems have proved their usefulness to calculate the burden of influenza disease in Spain using routine surveillance data, allowing us to estimate the impact of mild and severe influenza infection in Spain after the 2009 influenza pandemic.
Our results indicate that the seasonal influenza burden of both mild and severe influenza disease in Spain is virus‐ and age‐specific, with significant seasonal variation. During the 6 studied influenza seasons, we found that, while children under the age of 15 years have the highest ILI and MCIC rates, the very young (0‐4 years) and the elderly exhibit the highest rates of severe influenza‐associated hospitalizations. This is consistent with previous studies showing that young children and adolescents have the highest rates of medically attended influenza,7, 12, 13, 14 while the highest hospitalization rates for influenza are observed among very young15 and persons aged ≥65 years.16 Previous exposure to influenza viruses, providing a partial immunity to the circulating viruses, and higher vaccine coverage than in other age‐groups,17, 18 could account for the lower ILI rates at the primary care level in the elderly population. In addition, as the elderly have also the highest prevalence of chronic conditions, they would be more prone to complications and hospitalizations, once acquiring the influenza infection, therefore yielding higher hospitalization rates in this population group.19
General primary care practitioners in Spain attended about half a million ILI cases each season in young adults (15‐64 years) and between 40 000 and 90 000 in persons aged ≥65 years old. Pediatricians attended each season about 100 000 ILI cases in children <5 years of age and 200 000 children aged 5‐14 years. We observed a higher burden of mild influenza for all ages groups in the 2014‐2015 season, dominated by the A(H3N2) influenza virus, when the annual cumulative influenza rate was estimated at 2367 ILI cases/100 000 population, the highest rate since the 2009 pandemic, suggesting a high transmissibility of the virus A(H3N2) during 2014‐2015 epidemic.20 In elderly individuals, our findings suggest a higher burden of mild cases in the 2011‐2012 and 2014‐2015 influenza seasons, dominated by A(H3N2), consistent with the high incidence of medically attended illness in this population previously reported by other authors in primary care during the same period.21 During the influenza seasons, where influenza B was predominant (2012‐2013 season) or presented at a late peak of activity (2014‐2015 and 2015‐2016 influenza seasons), we found that the 5‐14 age‐group was considerably more affected compared to other influenza seasons. This finding was also described in other countries in Europe and in Australia.22, 23, 24 In children younger than 5 years, it is more difficult to find a virus‐specific pattern regarding the influenza disease burden. We found a high disease burden in seasons dominated by A(H1N1) (2015‐2016), but also in A(H3N2) dominant as the 2011‐2012 influenza season. This larger burden in very young children was also reported in many countries in Europe during the 2011‐2012 season, in accordance with a limited immunity against A(H3N2) virus, especially in younger age‐groups, after several influenza seasons without circulation of this influenza virus.25
We have estimated the burden of severe influenza during each influenza epidemic finding an average of 3616 SHCIC, 1232 ICU admissions, and 437 deaths in severe influenza hospitalized patients. The impact of severe influenza varied by age‐group and across the 6 studied influenza seasons.
As we mentioned above, the impact of severe influenza during the 6 studied influenza seasons, as measured by the cumulative hospitalization rate, was higher in Spain for children less than 5 years old and elderly. However, in terms of the number of severe influenza cases, young adults bore the largest burden of influenza hospitalization and ICU admission, followed by the elderly. These 2 groups accounted for 85% and almost 90% of the total number of SHCIC and patients admitted to ICU, respectively. Mortality was highest in the elderly with 58% of the deaths reported in influenza hospitalized patients, followed by 39% in young adults. Future studies are needed to explore if certain risk factors contribute to mortality in the young adults group (e.g, underlying conditions).
Overall, during the post‐2009 influenza pandemic period, the proportion of severe influenza cases admitted to the UCI was highest in young adults 15‐64 years old, consistent with other studies in the same period.26 In addition, the number of patients in this age‐group admitted to the ICU was higher in A(H1N1)pdm09 dominant seasons compared with other subtype seasons.26, 27
Children under 5 years of age experienced the highest number of SHCIC and ICU admissions during the season 2015‐2016, concordant with the high burden of mild disease in this age‐group observed in primary care in the 2015‐2016 season.28 However, there was no increase in the number of deaths in influenza hospitalized patients belonging to this age‐group.
In our study, influenza‐associated mortality increased with age, with the elderly having the highest hospitalization fatality rate, similarly to regression results describing the acute respiratory illness deaths attributable to influenza.15, 29 Consistently, we found the highest number of deaths in influenza hospitalized patients occurred in the elderly group in almost all seasons except the first post‐pandemic 2010‐2011 season. This was the only season when the number of deaths in severe influenza hospitalized patients in young adults was higher than in elderly. Moreover, higher numbers of deaths were observed in the young adults population in each season with important A(H1N1)pdm09 circulation, compared to other seasons. This is in line with the previously documented higher proportions of deaths among patients younger than 65 during the decade following each previous pandemic.30
The highest number of deaths in severe influenza hospitalized patients in the elderly was found in the 2014‐2015 influenza season dominated by A(H3N2), although high numbers of deaths were also observed for this age‐group in the preceding and subsequent A(H1N1)pdm09 seasons. It is accepted that influenza A(H3N2) can cause a relatively higher impact than other influenza viruses, mainly regarding the mortality within older age‐groups.29, 31 Interestingly, this was not reproduced in our study during the 2011‐2012 influenza season, dominated by A(H3N2) circulation. Some contributing factors might be related with limitations of the severe influenza surveillance in Spain, as we describe next.
The variation of the impact of severe influenza by season, for all age‐groups, is greater than that observed for mild disease. One of the reasons can be related with seasonal differences in influenza severity and/or the shorter time since the implementation of the surveillance system for SHCIC, but some other factors might have also influenced the findings. After the post‐pandemic 2010‐2011 influenza season, the perception of influenza threat and awareness of the hospital clinics contributing to the severe influenza surveillance, after more than 2 years with exhaustive work load due to “pandemic 2009”, might contribute to under‐notification of SHCIC which influenced the reported severe influenza burden in the 2011‐2012 and 2012‐2013 seasons. However, shortly before the peak of the 2013‐2014 epidemic, a local alert on severe influenza generated a huge media movement in Spain that changed the dynamic of the surveillance and increased the clinical awareness and therefore the recruitment and report of severe influenza cases to the system.32 Although we did not attempt to correct surveillance data for under‐detection, as other studies have carried out,33 the surveillance indicators did evidence an improvement in the SHCIC information reporting, assuming the consolidation of the system from the 2013‐2014 influenza season onwards. Thus, under‐ascertainment of SHCIC within the system may have occurred specially during the 2 seasons following the post‐pandemic 2010‐2011 influenza season, while a higher and more homogenous estimate of burden of severe influenza is found in this study for the last 3 studied seasons.28, 34
Several other limitations must be taken into account when interpreting our study results. Our estimation of severe influenza burden in Spain is restricted to surveillance data which includes severity criteria in the SHCIC case definition. Therefore, our results are conservative when compared to those based on the reporting of influenza hospitalized cases independently of its clinical severity,35 yielding lower hospitalization rates. This also applies to the number of deaths reported in influenza hospitalized patients. Results of regression models, previously applied in our group, gave an estimate of all causes excess mortality rate attributable to influenza of 170 deaths/100 000 population in the >64 age‐group for the 2011‐2012 influenza season.36 In contrast, during the 2011‐2012 influenza season, we registered 73 deaths in influenza hospitalized patients older than 64 years, yielding a rate of 1 death/100 000 population. Studies on the excess mortality attributable to influenza for the post‐2009 influenza pandemic period are ongoing and might provide additional knowledge regarding the impact of influenza epidemics on the mortality of the population in Spain.
A possible additional limitation when estimating the burden of severe disease can be derived from collecting only hospitalized cases and not those who are admitted for less than 24 hours to the emergence room. Likewise, admission to the ICU might be affected by clinical management criteria in the case of very elderly people.
Considering together the mentioned limitations, we believe our results underestimate the real burden of severe influenza disease in Spain. Nevertheless, updated influenza burden information will be essential to guide public health policy and control measures.
An underestimate of the burden of mild influenza may also have occurred, as the ILI case definition only captures a proportion of all symptomatic cases37 and is less sensitive compared to acute respiratory infection (ARI) case definition. However, the sentinel sample positivity is quite high in Spain compared to other countries and besides other factors this could be related to the high performance of ILI's ascertainment of the sentinel physicians belonging to the SISSS.38
Finally, direct comparisons with equivalent studies are difficult due to differences not only in the estimation methods, but also in the different case definitions used, surveillance protocols, sentinel physicians training, primary, and secondary healthcare systems characteristics, etc.
In conclusion, we report a considerable influenza disease burden in Spain, with significant seasonal and age variations. Children less than 15 years old yielded the highest influenza activity in primary care, while influenza hospitalization rates were highest among the very young children and the elderly. Nevertheless, the impact of influenza in the National Health System was mainly concentrated in young adults for mild influenza, and in young adults and elderly for severe influenza disease.
Estimates of mild and severe influenza disease burden in Spain will allow understanding the impact of the epidemics, including potential influenza pandemics, helping to guide decisions targeting influenza prevention and control. This information, periodically updated, will also be crucial to estimate the impact of influenza vaccination programs, contributing toward enhanced guidance for the development of long lasting and more efficient influenza vaccines.
CONFLICT OF INTEREST
The authors report no competing interests.
ACKNOWLEDGEMENT
We would like to acknowledge the longstanding contribution of all participating sentinel general practitioners and pediatricians of influenza sentinel surveillance networks in: Andalucía, Aragón, Asturias, Baleares, Canarias, Cantabria, Castilla La Mancha, Castilla y León, Cataluña, Comunitat Valenciana, Extremadura, Madrid, Navarra, País Vasco, La Rioja, Ceuta, and Melilla. We are also grateful to all professionals participating in the Spanish Influenza Surveillance System: epidemiologists, virologist, hospital, and laboratory teams, who have contributed to the study. We also thank Alin Manuel Gherasim for the manuscript revision.
APPENDIX 1.
1.1.
The Spanish Influenza Surveillance System includes the following:
Physicians of the influenza sentinel surveillance networks of Andalucía, Aragón, Asturias, Baleares, Canarias, Cantabria, Castilla la Mancha, Castilla y León, Cataluña, Comunidad Valenciana, Extremadura, Madrid, Navarra, País Vasco, La Rioja, Ceuta and Melilla; Andalucía: Virtudes Gallardo (Servicio de Epidemiología, Consejería de Salud); Jose María Navarro (Hospital Virgen de las Nieves de Granada). Aragón: Elisa Marco (Servicio de Vigilancia en Salud Pública, Dirección General de Salud Pública). Manuel Omeñaca (Hospital Universitario Miguel Servet). Asturias: Ismael Huertas (Dirección General de Salud Pública y Planificación, Consejería de Salud y Servicios Sanitarios); María de Oña (Hospital Universitario Central de Asturias de Oviedo). Baleares: Jaume Giménez (Servicio de Epidemiología, Dirección General de Salut Pública); Jordi Reina (Hospital Son Espases de Palma de Mallorca). Canarias: Lucas González (Servicio de Epidemiología y Prevención, Consejería de Sanidad); Carmen Pérez (Hospital Dr Negrín de Las Palmas de Gran Canarias). Cantabria: Luis Viloria (Sección de Epidemiología, Consejería de Sanidad, Trabajo y Servicios Sociales); Mónica Gozalo (Hospital Universitario Marqués de Valdecilla). Castilla la Mancha: Gonzalo Gutiérrez (Servicio de Epidemiología, Consejería de Sanidad). Castilla y León: Tomás Vega (Observatorio de Salud Pública, DGSP, Consejería de Sanidad); Socorro Fernández (Servicio de Epidemiología, DGSP, Consejería de Sanidad); Raúl Ortiz de Lejarazu (National Influenza Centre, Hospital Clínico Universitario de Valladolid). Cataluña: Nuria Torner (Subdirecció General de Vigilància i Resposta a Emergències en Salut Pública, Agència de Salut Pública, CIBERESP); María de los Ángeles Marcos (National Influenza Centre, Hospital Clínic de Barcelona). Comunitat Valenciana: Aurora López (Subdirección General de Epidemiologia y Vigilancia de la Salud, Conselleria de Sanitat); Francisco González (Subdirección General de Epidemiologia y Vigilancia de la Salud, y Sanidad Ambiental. DGSP, Conselleria de Sanitat Universal i Salut Publica); Concepción Gimeno (Consorci Hospital General Universitari de València). Extremadura: Julián Mauro Ramos (Subdirección de Epidemiología. Dirección General de Salud Pública, Servicio Extremeño de Salud); Guadalupe Rodríguez (Complejo Hospitalario San Pedro de Alcántara, Cáceres). Galicia: María Jesús Purriños (Dirección Xeral Saúde Pública de Galicia); Juan García Costa (Complejo Hospitalario Universitario de Orense); Sonia Pérez‐Castro (Complejo Hospitalario Universitario de Vigo). Madrid: Luis García (Servicio de Epidemiología. Dirección General de Salud Pública); Juan Carlos Galán (Hospital Universitario Ramón y Cajal). Murcia: Rocío García (Servicio de Epidemiología, Consejería de Sanidad); Antonio Moreno (Hospital Virgen de la Arrixaca de Murcia). Navarra: Jesús Castilla (Sección de Vigilancia de Enfermedades Transmisibles del Instituto de Salud Pública, CIBERESP); Mirian Fernández‐Alonso (Clínica Universidad de Navarra); Carmen Ezpeleta (Complejo Hospitalario de Navarra). País Vasco: Fernando González Carril (Servicio de Salud Pública, Departamento de Salud); Gustavo Cilla (Hospital Donostia de San Sebastián, CIBERES). La Rioja: Carmen Quiñones (Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública y Consumo); Miriam Blasco (Hospital San Pedro de Logroño). Ceuta: Ana Rivas (Sección de Vigilancia Epidemiológica, Consejería de Sanidad y Bienestar Social); José López (Hospital Universitario de INGESA). Melilla: Daniel Castrillejo (Servicio de Epidemiología, Dirección General de Sanidad y Consumo, Consejería de Bienestar Social y Sanidad). Francisco Pozo, Inmaculada Casas, (National Centre for Microbiology, National Influenza Reference Laboratory, National Influenza Centre, ISCIII). Salvador de Mateo (National Centre of Epidemiology, CIBERESP, ISCIII).
Oliva J, Delgado‐Sanz C, Larrauri A, the Spanish Influenza Surveillance System . Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010‐2016. Influenza Other Respi Viruses. 2018;12:161–170. https://doi.org/10.1111/irv.12499
The copyright line for this article was changed on 25 January 2018 after original online publication
[Correction added on 25 January 2018, after first online publication: Funding information has been added.]
Contributor Information
Amparo Larrauri, Email: alarrauri@isciii.es.
the Spanish Influenza Surveillance System:
Virtudes Gallardo, Jose María Navarro, Elisa Marco, Manuel Omeñaca, Ismael Huertas, María de Oña, Jaume Giménez, Lucas González, Carmen Pérez, Luis Viloria, Mónica Gozalo, Gonzalo Gutiérrez, Tomás Vega, Socorro Fernández, Nuria Torner, María de los Ángeles Marcos, Aurora López, Francisco González, Concepción Gimeno, Julián Mauro Ramos, Guadalupe Rodríguez, María Jesús Purriños, Juan García Costa, Sonia Pérez‐Castro, Luis García, Juan Carlos Galán, Rocío García, Antonio Moreno, Jesús Castilla, Mirian Fernández‐Alonso, Carmen Ezpeleta, Fernando González Carril, Gustavo Cilla, Carmen Quiñones, Miriam Blasco, Ana Rivas, José López, Francisco Pozo, Inmaculada Casas, and Salvador de Mateo
REFERENCES
- 1. World Health Organization Influenza (Seasonal) . Fact sheet November 2016. 2016.
- 2. Nicoll A, Ciancio BC, Lopez CV, et al. Influenza‐related deaths–available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe. Euro Surveill. 2012;17:20162. [DOI] [PubMed] [Google Scholar]
- 3. World Health Organization . A manual for estimating disease burden associated with seasonal influenza. 2015. http://www.who.int/influenza/resources/publications/manual_burden_of_disease/en/. Accessed January 15, 2017.
- 4. de Mateo S, Larrauri A, Mesonero C. Influenza surveillance. New solutions to an old problem. Gac Sanit. 2006;20:67‐73. [DOI] [PubMed] [Google Scholar]
- 5. Larrauri CA, Jimenez‐Jorge S, Mateo OS, Pozo SF, Ledesma MJ, Casas FI. Epidemiology of the 2009 influenza pandemic in Spain. The Spanish Influenza Surveillance System. Enferm Infecc Microbiol Clin. 2012;30(Suppl 4):2‐9. [DOI] [PubMed] [Google Scholar]
- 6. Larrauri A, de Mateo S. Characterisation of swabbing for virological analysis in the Spanish Influenza Sentinel Surveillance System during four influenza seasons in the period 2002‐2006. Euro Surveill. 2007;12:E5‐E6. [DOI] [PubMed] [Google Scholar]
- 7. Paget WJ, Balderston C, Casas I, et al. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr. 2010;169:997‐1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Gonzalez R, Balasso V, Uriona S, et al. Patient characteristics and health care burden during the influenza A (H1N1) 2009 pandemic in the university Hospital Vall d'Hebron of Barcelona. Enferm Infecc Microbiol Clin. 2011;29:593‐600. [DOI] [PubMed] [Google Scholar]
- 9. Torner N, Navas E, Soldevila N, et al. Costs associated with influenza‐related hospitalization in the elderly. Hum Vaccin Immunother. 2017;13:412‐416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. European Commission . Commission Decision of 30 April 2009 Amending DECISION 2002/253/EC Laying Down Case Definitions for Reporting Communicable Diseases to the Community Network Under Decision No 2119/98/EC of the European Parliament and of the Council. Luxembourg: Publications Office of the European Union; 2009. 1.5.2009. L 110. [Google Scholar]
- 11. Instituto Nacional de Estadística . Population Projections. 2017. http://www.ine.es/ . Accessed January 26, 2017.
- 12. Fleming DM, Taylor RJ, Haguinet F, et al. Influenza‐attributable burden in United Kingdom primary care. Epidemiol Infect. 2016;144:537‐547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Matias G, Haguinet F, Lustig RL, Edelman L, Chowell G, Taylor RJ. Model estimates of the burden of outpatient visits attributable to influenza in the United States. BMC Infect Dis. 2016;16:641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Poehling KA, Edwards KM, Griffin MR, et al. The burden of influenza in young children, 2004‐2009. Pediatrics. 2013;131:207‐216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect. 2014;68:363‐371. [DOI] [PubMed] [Google Scholar]
- 16. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993‐2008. Clin Infect Dis. 2012;54:1427‐1436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Jimenez‐Garcia R, Rodriguez‐Rieiro C, Hernandez‐Barrera V, et al. Negative trends from 2008/9 to 2011/12 seasons in influenza vaccination coverages among high risk subjects and health care workers in Spain. Vaccine. 2014;32:350‐354. [DOI] [PubMed] [Google Scholar]
- 18. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross‐sectional serological study. Lancet. 2010;375:1100‐1108. [DOI] [PubMed] [Google Scholar]
- 19. Mullooly JP, Bridges CB, Thompson WW, et al. Influenza‐ and RSV‐associated hospitalizations among adults. Vaccine. 2007;25:846‐855. [DOI] [PubMed] [Google Scholar]
- 20. Delgado‐Sanz C, Jiménez‐Jorge S, Pozo F, et al. Temporada 2014‐2015 (desde la semana 40/2014 hasta la semana 20/2015). Bol Epidemiol Semanal. 2015;23:80‐104. [Google Scholar]
- 21. Fowlkes A, Steffens A, Temte J, et al. Incidence of medically attended influenza during pandemic and post‐pandemic seasons through the Influenza Incidence Surveillance Project, 2009‐13. Lancet Respir Med. 2015;3:709‐718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. der An HM, Buchholz U. Estimation of influenza‐attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02‐2014/15. Influenza Other Respir Viruses. 2017;11:110‐121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Caini S, Huang QS, Ciblak MA, et al. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses. 2015;9(Suppl 1):3‐12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Moa AM, Muscatello DJ, Turner RM, MacIntyre CR. Epidemiology of influenza B in Australia: 2001‐2014 influenza seasons. Influenza Other Respir Viruses. 2017;11:102‐109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. European Centre for Disease Prevention and Control . Influenza in Europe – Season 2011‐2012. Stockholm: ECDC; 2012. http://ecdc.europa.eu/en/publications/Publications/Influenza-Europe-2011-2012-surveillance-report.pdf. 2017. Accessed February 15, 2017. [Google Scholar]
- 26. Boddington NL, Verlander NQ, Pebody RG. Developing a system to estimate the severity of influenza infection in England: findings from a hospital‐based surveillance system between 2010/2011 and 2014/2015. Epidemiol Infect. 2017;145:1461‐1470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Chaves SS, Aragon D, Bennett N, et al. Patients hospitalized with laboratory‐confirmed influenza during the 2010‐2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis. 2013;208:1305‐1314. [DOI] [PubMed] [Google Scholar]
- 28. Oliva Domínguez J, Delgado‐Sanz C, Pozo F, et al. Temporada 2015‐2016 (desde la semana 40/2015 hasta la semana 20/2016). Bol Epidemiol Semanal. 2016;24:60‐84. [Google Scholar]
- 29. Lopez‐Cuadrado T, de Mateo S, Jimenez‐Jorge S, Savulescu C, Larrauri A. Influenza‐related mortality in Spain, 1999‐2005. Gac Sanit. 2012;26:325‐329. [DOI] [PubMed] [Google Scholar]
- 30. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178:53‐60. [DOI] [PubMed] [Google Scholar]
- 31. Thompson WW, Weintraub E, Dhankhar P, et al. Estimates of US influenza‐associated deaths made using four different methods. Influenza Other Respir Viruses. 2009;3:37‐49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Delgado‐Sanz C, Jiménez‐Jorge S, Pozo F, et al. Vigilancia de la gripe en España. Temporada 2013‐2014 (desde la semana 40/2013 hasta la semana 20/2014).. Bol Epidemiol Semanal. 2014;22:146‐166. [Google Scholar]
- 33. Reed C, Chaves SS, Daily KP, et al. Estimating influenza disease burden from population‐based surveillance data in the United States. PLoS ONE. 2015;10:e0118369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Centro Nacional de Epidemiología . Vigilancia de casos graves hospitalizados confirmados de gripe en España. Temporada 2010‐11. Madrid: Instituto de Salud Carlos III; 2011. http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/Informe_casos_graves_hospitalizados_2010-2011_07septiembre2011.pdf. 2017. Accessed January 26, 2017. [Google Scholar]
- 35. Chaves SS, Lynfield R, Lindegren ML, Bresee J, Finelli L. The US Influenza Hospitalization Surveillance Network. Emerg Infect Dis. 2015;21:1543‐1550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Leon‐Gomez I, Delgado‐Sanz C, Jimenez‐Jorge S, et al. Excess mortality associated with influenza in Spain in winter 2012. Gac Sanit. 2015;29:258‐265. [DOI] [PubMed] [Google Scholar]
- 37. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775‐785. [DOI] [PubMed] [Google Scholar]
- 38. Negro E. Evaluation of the sentinel networks integrated into the Spanish Influenza Sentinel Surveillance System. Season 2007‐2008. 2017. http://www.isciii.es/ISCIII/es/. Accessed February 28, 2017.